{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:53:13Z","timestamp":1774507993835,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Laboratory Construction Project of Shanxi Provincial Department of Science and Technology","award":["202204010931007"],"award-info":[{"award-number":["202204010931007"]}]},{"name":"Shanxi Provincial Health Commission","award":["2020SYS11"],"award-info":[{"award-number":["2020SYS11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"DOI":"10.1186\/s12938-026-01545-2","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:45:01Z","timestamp":1773330301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of BMI, prognostic nutritional index, and CRP in patients with lymphoma after autologous hematopoietic stem cell transplantation"],"prefix":"10.1186","volume":"25","author":[{"given":"Jin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolian","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"5","key":"1545_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.21147\/j.issn.1000-9604.2022.05.01","volume":"34","author":"Health Commission Of The People\u2019s Republic Of China N","year":"2022","unstructured":"Health Commission Of The People\u2019s Republic Of China N. National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China (English version). Chin J Cancer Res. 2022;34(5):425\u201346.","journal-title":"Chin J Cancer Res"},{"issue":"12","key":"1545_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00389-w","volume":"10","author":"TJ Bakhshi","year":"2020","unstructured":"Bakhshi TJ, Georgel PT. Genetic and epigenetic determinants of diffuse large B-cell lymphoma. Blood Cancer J. 2020;10(12):123.","journal-title":"Blood Cancer J"},{"issue":"10","key":"1545_CR3","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1158\/1055-9965.EPI-20-0228","volume":"29","author":"L Moubadder","year":"2020","unstructured":"Moubadder L, McCullough LE, Flowers CR, Koff JL. Linking environmental exposures to molecular pathogenesis in Non-Hodgkin lymphoma subtypes. Cancer Epidemiol Biomarkers Prev. 2020;29(10):1844\u201355.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1545_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001235","volume":"8","author":"SS Neelapu","year":"2020","unstructured":"Neelapu SS, Adkins S, Ansell SM, Brody J, Cairo MS, Friedberg JW, et al. Society for immunotherapy of cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma. J Immunother Cancer. 2020;8(2):e001235.","journal-title":"J Immunother Cancer"},{"issue":"12","key":"1545_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1159\/000532090","volume":"101","author":"X Liu","year":"2023","unstructured":"Liu X, Zheng Y, Li H, Wang M, You MJ, Tian C. Efficacy of autologous hematopoietic stem cell transplantation versus chemotherapy or allogeneic hematopoietic stem cell transplantation for follicular lymphoma: systematic review and meta-analysis. Oncology. 2023;101(12):822\u201335.","journal-title":"Oncology"},{"issue":"7","key":"1545_CR6","doi-asserted-by":"publisher","first-page":"409.e1","DOI":"10.1016\/j.jtct.2022.04.012","volume":"28","author":"R Phelan","year":"2022","unstructured":"Phelan R, Chen M, Bupp C, Bolon YT, Broglie L, Brunner-Grady J, et al. Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes. Transplant Cell Ther. 2022;28(7):409.e1-409.e10.","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"1545_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235786","volume":"15","author":"D Terziev","year":"2020","unstructured":"Terziev D, Bauer M, Paschold L, Wickenhauser C, Wienke A, Binder M, et al. Impact of bone marrow involvement on outcome in relapsed and refractory transplant eligible diffuse large B-cell lymphoma and transformed indolent lymphoma. PLoS ONE. 2020;15(7):e0235786.","journal-title":"PLoS ONE"},{"issue":"9","key":"1545_CR8","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.clnu.2019.12.024","volume":"39","author":"RD Dolan","year":"2020","unstructured":"Dolan RD, Daly L, Sim WMJ, Fallon M, Ryan A, McMillan DC, et al. Comparison of the prognostic value of ECOG-PS, mGPS and BMI\/WL: implications for a clinically important framework in the assessment and treatment of advanced cancer. Clin Nutr. 2020;39(9):2889\u201395.","journal-title":"Clin Nutr"},{"issue":"3","key":"1545_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/jjco\/hyz175","volume":"50","author":"N Gondo","year":"2020","unstructured":"Gondo N, Sawaki M, Hattori M, Yoshimura A, Kotani H, Adachi Y, et al. Impact of BMI for clinical outcomes in Japanese breast cancer patients. Jpn J Clin Oncol. 2020;50(3):230\u201340.","journal-title":"Jpn J Clin Oncol"},{"key":"1545_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cca.2018.08.030","volume":"486","author":"Z Wang","year":"2018","unstructured":"Wang Z, Wang Y, Zhang X, Zhang T. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: review and meta-analysis. Clin Chim Acta. 2018;486:303\u201310.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1545_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.33160\/yam.2020.02.002","volume":"63","author":"T Matsunaga","year":"2019","unstructured":"Matsunaga T, Miyata H, Sugimura K, Motoori M, Asukai K, Yanagimoto Y, et al. Prognostic significance of C-reactive protein-to-prealbumin ratio in patients with esophageal cancer. Yonago Acta Med. 2019;63(1):8\u201319.","journal-title":"Yonago Acta Med"},{"issue":"8","key":"1545_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/jso.26823","volume":"125","author":"Z Huang","year":"2022","unstructured":"Huang Z, Cai P, Zhao Y, Niu D, Xu F, Lai Y, et al. Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer. J Surg Oncol. 2022;125(8):1238\u201350.","journal-title":"J Surg Oncol"},{"issue":"24","key":"1545_CR13","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1182\/bloodadvances.2021005171","volume":"5","author":"M Rodr\u00edguez","year":"2021","unstructured":"Rodr\u00edguez M, Alonso-Alonso R, Tom\u00e1s-Roca L, Rodr\u00edguez-Pinilla SM, Manso-Alonso R, Cereceda L, et al. Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers. Blood Adv. 2021;5(24):5588\u201398.","journal-title":"Blood Adv"},{"key":"1545_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.863269","volume":"12","author":"S Liu","year":"2022","unstructured":"Liu S, Liu W, Li H, Yang L, Song Y, Zhang X, et al. Epidemiological characteristics of peripheral T-cell lymphoma: a population-based study. Front Oncol. 2022;12:863269.","journal-title":"Front Oncol"},{"key":"1545_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1088685","volume":"14","author":"Z Yan","year":"2023","unstructured":"Yan Z, Yao S, Wang Z, Zhou W, Yao Z, Liu Y. Treatment of extranodal NK\/T-cell lymphoma: from past to future. Front Immunol. 2023;14:1088685.","journal-title":"Front Immunol"},{"issue":"11","key":"1545_CR16","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.3324\/haematol.2023.284070","volume":"108","author":"MJ Maurer","year":"2023","unstructured":"Maurer MJ. The international prognostic index in aggressive B-cell lymphoma. Haematologica. 2023;108(11):2874\u20139.","journal-title":"Haematologica"},{"issue":"2","key":"1545_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s40620-019-00654-7","volume":"33","author":"ID Kostakis","year":"2020","unstructured":"Kostakis ID, Kassimatis T, Bianchi V, Paraskeva P, Flach C, Callaghan C, et al. UK renal transplant outcomes in low and high BMI recipients: the need for a national policy. J Nephrol. 2020;33(2):371\u201381.","journal-title":"J Nephrol"},{"issue":"5","key":"1545_CR18","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.1212\/WNL.0000000000007861","volume":"93","author":"O Nakken","year":"2019","unstructured":"Nakken O, Meyer HE, Stigum H, Holm\u00f8y T. High BMI is associated with low ALS risk: a population-based study. Neurology. 2019;93(5):e424\u201332.","journal-title":"Neurology"},{"issue":"11","key":"1545_CR19","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1080\/10428194.2021.1929956","volume":"62","author":"D Chihara","year":"2021","unstructured":"Chihara D, Larson MC, Robinson DP, Thompson CA, Maurer MJ, Casulo C, et al. Body mass index and survival of patients with lymphoma. Leuk Lymphoma. 2021;62(11):2671\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"1545_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00515-2","volume":"11","author":"K Wudhikarn","year":"2021","unstructured":"Wudhikarn K, Bansal R, Khurana A, Hathcock MA, Bennani NN, Paludo J, et al. The impact of obesity and body weight on the outcome of patients with relapsed\/refractory large B-cell lymphoma treated with axicabtagene ciloleucel. Blood Cancer J. 2021;11(7):124.","journal-title":"Blood Cancer J"},{"issue":"11","key":"1545_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225035","volume":"14","author":"S Scheich","year":"2019","unstructured":"Scheich S, En\u00dfle JC, M\u00fccke VT, Acker F, Aspacher L, Wolf S, et al. Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantation. PLoS ONE. 2019;14(11):e0225035.","journal-title":"PLoS ONE"},{"issue":"1","key":"1545_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/01635581.2021.1881570","volume":"74","author":"C Vlooswijk","year":"2022","unstructured":"Vlooswijk C, Oerlemans S, Ezendam NPM, Schep G, Slot S, Thong MSY, et al. Physical activity is associated with health related quality of life in lymphoma survivors regardless of body mass index; results from the profiles registry. Nutr Cancer. 2022;74(1):158\u201367.","journal-title":"Nutr Cancer"},{"issue":"8","key":"1545_CR23","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1245\/s10434-013-2926-5","volume":"20","author":"K Migita","year":"2013","unstructured":"Migita K, Takayama T, Saeki K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. 2013;20(8):2647\u201354.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1545_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.urolonc.2021.05.028","volume":"39","author":"SI Kim","year":"2021","unstructured":"Kim SI, Kim SJ, Kim SJ, et al. Prognostic nutritional index and prognosis in renal cell carcinoma: a systematic review and meta-analysis. Urol Oncol. 2021;39(10):623\u201330.","journal-title":"Urol Oncol"},{"key":"1545_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.656741","volume":"9","author":"L Chen","year":"2021","unstructured":"Chen L, Bai P, Kong X, et al. Prognostic Nutritional Index (PNI) in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator. Front Cell Dev Biol. 2021;9:656741.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1545_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1024\/0300-9831\/a000737","volume":"92","author":"R Mungmunpuntipantip","year":"2022","unstructured":"Mungmunpuntipantip R, Wiwanitkit V. Prognostic nutritional index, immune nutritional status and COVID-19[J]. Int J Vitam Nutr Res. 2022;92(1):3.","journal-title":"Int J Vitam Nutr Res"},{"issue":"8","key":"1545_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1590\/1806-9282.20210460","volume":"67","author":"AL Sertdemir","year":"2021","unstructured":"Sertdemir AL, \u0130cli A, Aribas A, et al. Prognostic nutritional index and the risk of acute kidney injury in patients with acute coronary syndrome. Rev Assoc Med Bras (1992). 2021;67(8):1124\u20139.","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"4","key":"1545_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/10428194.2021.2010064","volume":"63","author":"P Mozas","year":"2022","unstructured":"Mozas P, Rivero A, Rivas-Delgado A, Nadeu F, Gin\u00e9 E, Delgado J, et al. The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma. Leuk Lymphoma. 2022;63(4):903\u201310.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"1545_CR29","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00423-022-02508-6","volume":"407","author":"S Maruyama","year":"2022","unstructured":"Maruyama S, Okamura A, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, et al. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbecks Arch Surg. 2022;407(5):1901\u20139.","journal-title":"Langenbecks Arch Surg"},{"issue":"Suppl 6","key":"1545_CR30","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/j.htct.2023.11.005","volume":"46","author":"E Negreiros","year":"2024","unstructured":"Negreiros E, Bueno da Silveira TM, Fortier SC, Chiattone CS. Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin\u2019s Lymphoma. Hematol Transfus Cell Ther. 2024;46(Suppl 6):S53\u20138.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"1545_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1184","volume":"12","author":"C Guo","year":"2024","unstructured":"Guo C, Wang H, Wang X, Tian S. High CRP\/PNI levels predict an unfavorable prognosis in severe fever with thrombocytopenia syndrome: a propensity score matching study. Immun Inflamm Dis. 2024;12(2):e1184.","journal-title":"Immun Inflamm Dis"},{"key":"1545_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.878457","volume":"13","author":"L Zeng","year":"2022","unstructured":"Zeng L, Li SH, Xu SY, Chen K, Qin LJ, Liu XY, et al. Clinical significance of a CD3\/CD8-based immunoscore in neuroblastoma patients using digital pathology. Front Immunol. 2022;13:878457. https:\/\/doi.org\/10.3389\/fimmu.2022.878457.","journal-title":"Front Immunol"},{"key":"1545_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1058165","volume":"2016","author":"M \u017babi\u0144ska","year":"2016","unstructured":"\u017babi\u0144ska M, Krajewska M, Ko\u015bcielska-Kasprzak K, Klinger M. CD3(+)CD8(+)CD28(-) T lymphocytes in patients with lupus nephritis. J Immunol Res. 2016;2016:1058165. https:\/\/doi.org\/10.1155\/2016\/1058165.","journal-title":"J Immunol Res"},{"issue":"2","key":"1545_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9020042","volume":"9","author":"N Hiltunen","year":"2021","unstructured":"Hiltunen N, V\u00e4yrynen JP, B\u00f6hm J, Helminen O. CD3+, CD8+, CD4+ and FOXP3+ T cells in the immune microenvironment of small bowel neuroendocrine tumors. Diseases. 2021;9(2):42. https:\/\/doi.org\/10.3390\/diseases9020042.","journal-title":"Diseases"},{"issue":"9","key":"1545_CR35","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/vaccines11091474","volume":"11","author":"MM Saber","year":"2023","unstructured":"Saber MM. PD-L1 is involved in the development of non-Hodgkin\u2019s lymphoma by mediating circulating lymphocyte apoptosis. Vaccines (Basel). 2023;11(9):1474.","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"1545_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/hon.3003","volume":"40","author":"YB Hagos","year":"2022","unstructured":"Hagos YB, Akarca AU, Ramsay A, Rossi RL, Pomplun S, Ngai V, et al. High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma. Hematol Oncol. 2022;40(4):541\u201353.","journal-title":"Hematol Oncol"},{"issue":"22","key":"1545_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000042165","volume":"104","author":"T Cetintepe","year":"2025","unstructured":"Cetintepe T, Cetintepe L, Unal DK, Aygun K, Solmaz S. HALP score and GNRI: simple and powerful prognostic markers in diffuse large B-cell lymphoma. Medicine (Baltimore). 2025;104(22):e42165.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"1545_CR38","doi-asserted-by":"publisher","first-page":"769.e1","DOI":"10.1016\/j.jtct.2021.05.026","volume":"27","author":"LF Porrata","year":"2021","unstructured":"Porrata LF, Burgstaler EA, Winters JL, Jacob E, Inwards DJ, Ansell SM, et al. Infused autograft absolute lymphocyte count predicts superior survival in diffuse large B cell lymphoma patients post-autologous peripheral blood hematopoietic stem cell transplantation: a matched case-control study. Transplant Cell Ther. 2021;27(9):769.e1-769.e8.","journal-title":"Transplant Cell Ther"},{"issue":"Supplement 1","key":"1545_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1182\/blood-2020-135952","volume":"136","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chen B. Analysis of risk factors related to relapse and refractory DLBCL and study of DLBCL maintenance therapy. Blood. 2020;136(Supplement 1):32\u20133.","journal-title":"Blood"},{"issue":"12","key":"1545_CR40","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jcyt.2023.07.005","volume":"25","author":"Y Jeon","year":"2023","unstructured":"Jeon Y, Kim TY, Min GJ, Park SS, Park S, Yoon JH, et al. Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients. Cytotherapy. 2023;25(12):1307\u201316.","journal-title":"Cytotherapy"},{"key":"1545_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-025-04118-6","author":"S Fuji","year":"2025","unstructured":"Fuji S, Ohmoto A. Current status of hematopoietic cell transplantation in patients with peripheral T-cell lymphoma including adult T-cell leukemia-lymphoma. Int J Hematol. 2025. https:\/\/doi.org\/10.1007\/s12185-025-04118-6.","journal-title":"Int J Hematol"},{"issue":"9","key":"1545_CR42","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/ijc.33369","volume":"148","author":"F Saberi Hosnijeh","year":"2021","unstructured":"Saberi Hosnijeh F, Casabonne D, Nieters A, Solans M, Naudin S, Ferrari P, et al. Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: an exposome-wide analysis. Int J Cancer. 2021;148(9):2115\u201328.","journal-title":"Int J Cancer"},{"key":"1545_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1663066","volume":"16","author":"J Zhou","year":"2025","unstructured":"Zhou J, Yao J, Hu N, Su J. Associations between gut microbiota and immune status in untreated B-cell lymphoma patients. Front Immunol. 2025;16:1663066.","journal-title":"Front Immunol"},{"issue":"7","key":"1545_CR44","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"10","key":"1545_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30706-4","volume":"18","author":"T Tanimoto","year":"2017","unstructured":"Tanimoto T, Oshima K, Tsuda K, Mori J, Shimmura H. Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma. Lancet Oncol. 2017;18(10):e557.","journal-title":"Lancet Oncol"},{"issue":"11","key":"1545_CR46","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.6004\/jnccn.2020.0053","volume":"18","author":"SM Horwitz","year":"2020","unstructured":"Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, et al. NCCN guidelines insights: T-cell lymphomas, version 1.2021. J Natl Compr Canc Netw. 2020;18(11):1460\u20137.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12938-026-01545-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-026-01545-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-026-01545-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:47:36Z","timestamp":1774500456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12938-026-01545-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1186\/s12938-026-01545-2","relation":{},"ISSN":["1475-925X"],"issn-type":[{"value":"1475-925X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Cancer Hospital Affiliated to Shanxi Medical University (2020Y16). Informed consent was obtained from participants for the participation in the study and all methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}